Page 10 - PERIODIC Magazine Issue 5
P. 10

N      ew Research continued








                 Nicky Farrer                                     inactive, but upon treatment with ultrasound they are
                                                                  destroyed and readily release the drug. A focussed beam
                 Metal-based systems for
                 targeted drug delivery                           of ultrasound in a cancerous region will release and
                                                                  catapult the platinum (IV) compound deep into the tumour,
                                                                  where they are reduced to the active platinum (II) form.
                 Dr Farrer’s multi-disciplinary*                  Ultrasound is a promising technique for drug delivery as it
                 research aims to develop metal-                  can be highly focused, meaning drugs will only be released
                 based systems that respond to                    and taken up by specific, targeted, cancerous cells. It is
                 ultrasound for targeted drug                     envisaged that lower drug doses will be required, resulting
                 delivery of anti-cancer drugs, for               in less undelivered drug in the body and reduced side-
                 improved quality and length of life of cancer patients.     effects of the treatment. Ultrasound can also penetrate
                 Platinum (II) compounds are well-established, highly   deeply into the body meaning that a number of different
                 effective anti-cancer agents, found in around 50% of   cancers can be accessed.
                 chemotherapy treatments. Platinum compounds kill   *Dr Farrer is collaborating with researchers in the
                 cells by binding to DNA which stops aggressive tumours   Department of Chemistry and the Institute of Biomedical
                 from developing. However, without targeted delivery   Engineering, University of Oxford.
                 mechanisms, they will also attack healthy cells, leading to
                 severe side-effects such as nausea and permanent kidney
                 damage.
                 Dr Farrer is designing new platinum
                 (IV) drugs that are less toxic in the
                 bloodstream than traditional platinum
                 (II) drugs. The drugs are encapsulated
                 inside liposomes (vesicles made of
                 lipid bilayers) and attached to a larger
                 gas-filled bubble, making a drug
                 delivery vehicle (approximately the
                 size of a red blood cell). The drug
                 delivery vehicles are being designed
                 to respond to external stimuli: in the
                 absence of ultrasound they remain




























                 Read more at http://research.chem.ox.ac.uk/nicola-farrer.aspx



             10
                 Periodic       The Magazine of the Department of Chemistry
   5   6   7   8   9   10   11   12   13   14   15